Latest Headlines

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
PR Newswire

PR Newswire

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39

7 小时前

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
PR Newswire

PR Newswire

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

8 小时前

VolitionRx Announces Pricing of $4.6 Million Public Offering
PR Newswire

PR Newswire

VolitionRx Announces Pricing of $4.6 Million Public Offering

9 小时前

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
PR Newswire

PR Newswire

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

10 小时前

CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN
PR Newswire

PR Newswire

CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN

10 小时前

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
PR Newswire

PR Newswire

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

11 小时前

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
PR Newswire

PR Newswire

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

12 小时前

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
PR Newswire

PR Newswire

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

12 小时前

Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW
PR Newswire

PR Newswire

Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW

14 小时前

MimiSilk feiert 12 Jahre fortschrittliche Pflege mit neuen Produkten und Jubiläumsverkauf
PR Newswire

PR Newswire

MimiSilk feiert 12 Jahre fortschrittliche Pflege mit neuen Produkten und Jubiläumsverkauf

15 小时前